{"gene":"SULF1","run_date":"2026-04-28T21:42:57","timeline":{"discoveries":[{"year":2003,"finding":"HSulf-1 is a cell surface-associated heparan sulfate 6-O-endosulfatase that removes 6-O-sulfate groups from cell surface HSPGs, thereby diminishing phosphorylation of receptor tyrosine kinases (including FGFR and EGFR family members) that require sulfated HSPGs as co-receptors, and attenuating downstream ERK signaling in response to FGF-2 and HB-EGF.","method":"Re-expression of HSulf-1 in ovarian cancer cell lines; measurement of HSPG sulfation, RTK phosphorylation, and ERK pathway activation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain-of-function with multiple orthogonal readouts (sulfation, phosphorylation, signaling, proliferation, apoptosis); foundational paper replicated broadly","pmids":["12686563"],"is_preprint":false},{"year":2004,"finding":"HSulf-1 re-expression attenuates HGF-mediated phosphorylation of c-Met and downstream ERK/MAPK and Akt signaling, and reduces HGF-mediated cell motility and invasion in head and neck squamous carcinoma cells.","method":"Stable transfection of HSulf-1 in SCCHN cell lines; transwell invasion assay; Western blot for phospho-c-Met, phospho-ERK, phospho-Akt","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — clean gain-of-function with multiple orthogonal mechanistic readouts; replicated the HSPG-co-receptor mechanism for a new growth factor axis","pmids":["14973553"],"is_preprint":false},{"year":2005,"finding":"HSulf-1 and HSulf-2 have similar in vivo functions; their extracellular sulfatase activity is restricted to the local tumor cell surface, and their expression promotes extracellular matrix deposition within tumors while dramatically reducing myeloma tumor growth in SCID mice.","method":"Stable transfection of myeloma cells with HSulf-1 or HSulf-2 cDNA; in vivo SCID mouse xenograft model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vivo loss/gain-of-function with clear cellular and molecular phenotypes; independently replicated functional equivalence","pmids":["16192265"],"is_preprint":false},{"year":2006,"finding":"HSulf-1 expression in breast carcinoma cells inhibits angiogenesis in vivo by reducing the ability of vascular endothelial cell heparan sulfate to form a complex with FGF-2 and its receptor FGFR1c; shRNA knockdown of HSulf-1 in HUVECs enhances proliferation mediated by HS-dependent growth factors (FGF-2, HGF, VEGF165) but not HS-independent VEGF121.","method":"shRNA knockdown; Matrigel plug assay; CD31 staining; co-immunoprecipitation of FGF-2/FGFR1c/heparan sulfate complex; xenograft model","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including co-immunoprecipitation and in vivo data; mechanistically specific to HS-dependent signaling","pmids":["16778174"],"is_preprint":false},{"year":2007,"finding":"SULF1 and SULF2 act as major regulators of heparan sulfate 6-O-desulfation in vivo; they reduce GDNF binding to HS and enhance GDNF signaling and neurite sprouting, functioning as essential regulators of GDNF-dependent neural innervation in the embryonic esophagus.","method":"Sulf1/Sulf2 double-knockout mice; biochemical HS sulfation analysis; GDNF binding assays; neurite sprouting assays; genetic epistasis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo knockout with biochemical and cell signaling validation; first in vivo evidence for Sulf regulation of specific growth factor signaling","pmids":["17720696"],"is_preprint":false},{"year":2007,"finding":"Sulf1 and Sulf2 play overlapping yet critical roles in mouse development; neither single knockout showed significant flaws, but Sulf1/Sulf2 double knockout mice exhibited highly penetrant neonatal lethality with skeletal and renal abnormalities, demonstrating functional redundancy.","method":"Genetic knockout mice (Sulf1-/-, Sulf2-/-, double KO); phenotypic analysis of development and survival","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — clean double KO with clear survival phenotype; strong genetic evidence for functional redundancy","pmids":["17593974"],"is_preprint":false},{"year":2007,"finding":"Quail Sulf1 is an asparagine-linked glycosylated protein; N-linked glycosylation at sites in the enzymatic and C-terminal domains is essential for its enzymatic activity, membrane targeting, secretion, heparin binding, and 6-O-desulfation activity.","method":"Domain mapping with deletion mutants; glycosylation inhibitor studies; N-glycanase cleavage; heparin binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assays plus mutagenesis/domain analysis; identifies essential post-translational modification for function","pmids":["17855356"],"is_preprint":false},{"year":2007,"finding":"HSulf-1 loss in breast cancer cells triggers autocrine activation of the EGFR-ERK pathway through heparin-binding growth factors amphiregulin and HB-EGF; HSulf-1 inhibits this autocrine loop, reducing cyclin D1 levels and altering cell cycle distribution.","method":"shRNA-mediated HSulf-1 knockdown; neutralizing antibodies against amphiregulin and HB-EGF; Western blot for phospho-ERK, cyclin D1; cell cycle analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods identifying specific autocrine ligands; reciprocal KD and rescue experiments","pmids":["17363371"],"is_preprint":false},{"year":2007,"finding":"HSulf-1 expression is epigenetically silenced in ovarian cancer through DNA methylation of CpG sites in exon 1A and histone H3 methylation at the promoter; 5-aza-2'-deoxycytidine treatment restores HSulf-1 transcription.","method":"Bisulfite sequencing; chromatin immunoprecipitation (ChIP) for histone H3 methylation; 5-aza-2'-deoxycytidine treatment","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 — bisulfite sequencing plus ChIP with functional restoration experiment","pmids":["17310998"],"is_preprint":false},{"year":2009,"finding":"The unique hydrophilic domain (HD) of Sulf1 (~320 amino acids, positively charged) is required for enzymatic activity and functions as a high-affinity heparin/heparan sulfate interaction domain with nanomolar affinity; the outer regions of the HD mediate HS binding, and substrate 6-O-sulfate groups are required for association, suggesting that substrate turnover facilitates enzyme release.","method":"HD deletion mutants; GST-HD fusion proteins; surface plasmon resonance; heparinase treatment; FGF-2 signaling assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with domain mutants, surface plasmon resonance quantification, and functional signaling readout","pmids":["19666466"],"is_preprint":false},{"year":2009,"finding":"HSulf-1 and HSulf-2 selectively remove 6-O-sulfate groups from N,6-O,2-O trisulfated disaccharides in intact heparan sulfate on the cell surface; both Sulf activities are potently inhibited by the sulfated heparin mimetic PI-88.","method":"Flow cytometry with anti-HS antibody RB4CD12; disaccharide analysis by HPLC; ELISA with purified recombinant enzymes; in vivo activity on brain microvessels","journal":"Glycobiology","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic characterization with multiple substrates and inhibitor testing","pmids":["19822709"],"is_preprint":false},{"year":2009,"finding":"Variant hepatic nuclear factor 1 (vHNF1/HNF1β) is a transcriptional repressor of HSulf-1 in ovarian cancer; vHNF1 binds to two responsive elements in the HSulf-1 promoter and suppresses its expression, reducing sensitivity to cisplatin.","method":"shRNA knockdown of vHNF1; reporter assay; chromatin immunoprecipitation (ChIP); xenograft model with cisplatin treatment","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus reporter assay plus functional rescue; identifies specific transcriptional repressor","pmids":["19487294"],"is_preprint":false},{"year":2009,"finding":"Promoter hypermethylation of the HSulf-1 gene's 5' regulatory region (approximately 400 bp) correlates with HSulf-1 silencing in human breast and gastric cancer cell lines and tissue samples.","method":"Cloning of 5' promoter region; bisulfite sequencing; correlation of methylation with expression","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — direct bisulfite sequencing with expression correlation; single lab","pmids":["19006069"],"is_preprint":false},{"year":2009,"finding":"A novel shorter SULF1 splice variant (SULF1B) antagonizes the canonical SULF1A: while SULF1A enhances Wnt signalling, SULF1B inhibits Wnt signalling and promotes angiogenesis, with both isoforms expressed in a developmental stage-specific manner.","method":"Cloning and expression of SULF1 splice variants; Wnt signaling reporter assays; angiogenesis assays; expression analysis in developing tissues","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 — functional assays identifying opposing activities; single lab with multiple readouts","pmids":["19577565"],"is_preprint":false},{"year":2011,"finding":"HSulf-1 inhibits autocrine EGFR-ERK signaling through heparin-binding growth factors in breast cancer cells; HSulf-1 expression is transcriptionally repressed under hypoxia via HIF-1α and HIF-2α binding to two functional hypoxia-responsive elements on the native HSulf-1 promoter.","method":"HIF-1α knockdown; chromatin immunoprecipitation with HIF-1α and HIF-2α antibodies; shRNA depletion; bFGF2 signaling assays; invasion assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP confirming direct HIF binding to native promoter plus functional rescue; identifies specific transcriptional regulatory mechanism","pmids":["21266348"],"is_preprint":false},{"year":2011,"finding":"HSulf-1 re-expression downregulates VEGFR-2 phosphorylation in ovarian and hepatocellular cancer cells, suppressing angiogenesis; shRNA knockdown of HSulf-1 enhances phospho-VEGFR-2 recovery.","method":"HSulf-1 expression vectors and shRNA; Western blot for phospho-VEGFR-2; xenograft tumor model; microvessel density analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal gain and loss of function with phosphorylation readout; single lab","pmids":["21853101"],"is_preprint":false},{"year":2011,"finding":"HSulf-1 inhibits Wnt/β-catenin signaling at the cell surface in gastric cancer cells that depend on extracellular Wnt signaling (MKN28), but has no effect in cells with constitutively active intracellular Wnt pathway (AGS), demonstrating that Sulf1 modulates Wnt signaling upstream at the HSPG level.","method":"HSulf-1 transfection; Wnt/β-catenin reporter assay; Wnt3a cDNA rescue; β-catenin shRNA; HSPG epitope analysis","journal":"Cancer science","confidence":"High","confidence_rationale":"Tier 2 — epistasis experiment with Wnt3a rescue and β-catenin knockdown defining pathway position; multiple orthogonal approaches","pmids":["21722266"],"is_preprint":false},{"year":2012,"finding":"Sulf1 and Sulf2 differentially generate organ-specific sulfation patterns of heparan sulfate in vivo; Sulf1 predominantly acts on UA2S-GlcNS6S trisulfated disaccharides, and Sulf1 mRNA expression levels in different organs correlate with the degree of HS desulfation in those organs.","method":"Disaccharide analysis of heparan sulfate from Sulf1 and Sulf2 knockout mice by HPLC; organ-specific expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical substrate analysis in knockout animals across multiple organs","pmids":["22298771"],"is_preprint":false},{"year":2013,"finding":"Sulf1 (and human Sulf1 expressed in Drosophila) inhibits the binding of Wingless/Wnt to Dally (an HSPG), reduces extracellular Wg protein levels by facilitating Wg degradation, and negatively regulates Wg/Wnt signaling; the fate of Wnt ligands upon Sulf action is context-dependent.","method":"In vitro, in vivo, and ex vivo systems in Drosophila; HS-Wg interaction assays; Wg stability measurement; human Sulf1 expression in Drosophila wing disc","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple complementary systems (in vitro, in vivo, ex vivo) with mechanistic dissection of Wnt ligand fate","pmids":["23300081"],"is_preprint":false},{"year":2013,"finding":"The hydrophilic domain (HD) of Sulf1 contains at least two separate HS-binding sites (inner and C-terminal regions) that cooperate for processive enzymatic action along HS chains; full-length Sulf1 shows broader GAG interaction while HD alone is highly specific for HS/heparin containing 6-O-sulfate substrate groups.","method":"Affinity chromatography; AFM single-molecule force spectroscopy; immunofluorescence on living cells; HD subdomain constructs","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 — single-molecule biophysics plus domain mapping; mechanistically resolves HD subdomain contributions","pmids":["23891937"],"is_preprint":false},{"year":2013,"finding":"TNF-α induces Sulf-1 expression in fibroblasts via NF-κB, ERK1/2, and p38 MAPK signaling, leading to 6-O-desulfation of cell surface HS and attenuation of FGF-1-mediated ERK1/2 activation and cell proliferation; siRNA silencing of Sulf-1 restores FGF-1 responsiveness.","method":"TNF-α treatment of MRC-5 fibroblasts; HS compositional analysis; siRNA knockdown; ERK1/2 activation assay; proliferation assay","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA rescue with biochemical and functional readouts; single lab","pmids":["27693418"],"is_preprint":false},{"year":2014,"finding":"Loss of HSulf-1 promotes tumorigenicity in ovarian cancer by decreasing Bim (pro-apoptotic) expression through increased p-ERK; ERK inhibition with PD98059 restores Bim levels, while PI3K/AKT inhibition does not, placing HSulf-1's effect on Bim specifically in the ERK pathway.","method":"shRNA knockdown; re-expression constructs; pharmacological inhibitors (PD98059, LY294002); Western blot for Bim; soft agar colony assay; xenograft model","journal":"International journal of cancer","confidence":"High","confidence_rationale":"Tier 2 — epistasis via pathway-specific inhibitors; reciprocal rescue; in vivo validation","pmids":["24596063"],"is_preprint":false},{"year":2014,"finding":"Sulf1 modulates BMP and FGF signaling during zebrafish trunk development: sulf1 knockdown decreases Pax7-expressing dermomyotome cells and sdf1/cxcl12 expression, both of which are restored by BMP signaling inhibition, while FGF signaling activation rescues neuromast deposition.","method":"Antisense morpholino knockdown in zebrafish; pharmacological inhibition/activation of BMP and FGF; in situ hybridization for pathway markers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — epistasis via pharmacological inhibitors with specific pathway placement; multiple developmental readouts","pmids":["23583585"],"is_preprint":false},{"year":2014,"finding":"Sulf1 restricts Shh ligand diffusion in the Xenopus neural tube by promoting ventral accumulation of Shh protein; Sulf1 knockdown leads to a less steep Shh gradient and altered ventral neural progenitor specification.","method":"Single-cell mRNA injection of GFP-tagged Shh; morpholino knockdown; in situ hybridization for Shh protein distribution and neural progenitor markers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — direct visualization of morphogen distribution with loss-of-function; links Sulf1 enzymatic activity to ligand gradient shaping","pmids":["24768893"],"is_preprint":false},{"year":2014,"finding":"Sulf1 plays an essential role in arterial specification in zebrafish by promoting VegfA165-mediated signaling; sulf1 morphants show reduced Notch and ephrinB2 expression in the dorsal aorta with increased venous marker flt4, rescued by vegfa165 mRNA co-injection.","method":"Antisense morpholino knockdown in zebrafish; vegfa165 mRNA rescue; in situ hybridization for arterial/venous markers; in vitro VEGFA-mediated signaling assays","journal":"Angiogenesis","confidence":"High","confidence_rationale":"Tier 2 — morpholino knockdown with mRNA rescue and specific pathway marker analysis; in vitro confirmation","pmids":["23959107"],"is_preprint":false},{"year":2015,"finding":"The HD of Sulf1 exhibits catch bond behavior with heparan sulfate; the catch bond character is attributed specifically to the 6-O-sulfation site on GAGs (slip bond only without 6-O-sulfation), characterized by two coupled slip-bond states with an energy difference of ~9 kBT.","method":"AFM-based force clamp spectroscopy; dynamic force spectroscopy; two-state two-path model analysis","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 — single-molecule biophysics with quantitative thermodynamic characterization of binding mechanism","pmids":["25863062"],"is_preprint":false},{"year":2015,"finding":"Sulf1 has ligand-specific effects on Wnt signaling: it inhibits canonical Wnt8a signaling while enhancing non-canonical Wnt11b activity, and differentially affects membrane accumulation and extracellular levels of Wnt8a versus Wnt11b ligands.","method":"Wnt signaling assays in Xenopus; fluorescently tagged Wnt ligand imaging in ectodermal explants; Sulf1 overexpression","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — direct visualization of ligand distribution with functional signaling readouts; single lab","pmids":["25681501"],"is_preprint":false},{"year":2015,"finding":"Sulf1 deficiency in cerebellar granule cells results in reduced neurite length, reduced cell survival, and reduced migration capacity, correlated with Sulf-specific interference with FGF2, GDNF, and NGF signaling pathways; Sulf2 deficiency alters a specific HS epitope on cerebellar neuron surfaces.","method":"Primary cerebellar granule cells from Sulf1/Sulf2 knockout mice; neurite length measurement; survival assays; migration assays; biochemical HS analysis; HS epitope detection","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — primary cell KO with multiple orthogonal functional readouts and biochemical HS characterization","pmids":["26448642"],"is_preprint":false},{"year":2015,"finding":"HSulf-1 loss promotes aerobic glycolysis (Warburg effect) in ovarian cancer by upregulating glycolytic genes (Glut1, HKII, LDHA) and blocking glucose entry into the TCA cycle via increased inhibitory phosphorylation of pyruvate dehydrogenase; mechanistically, HSulf-1 loss promotes c-Myc induction through HB-EGF-mediated p-ERK activation.","method":"shRNA silencing; HSulf-1 overexpression; metabolomic profiling; isotope tracer analysis; oxygen consumption rate measurement; pharmacological c-Myc inhibition; PG545 treatment","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 1–2 — isotope tracer metabolomics plus pharmacological epistasis; multiple orthogonal methods identifying HB-EGF/ERK/c-Myc as the mechanism","pmids":["26378042"],"is_preprint":false},{"year":2017,"finding":"Desulfation of heparan sulfate by Sulf1 and Sulf2 is required for corticospinal tract axon guidance; in Sulf1/2 double KO mice, increased 6-O-sulfated HS causes abnormal accumulation of Slit2 protein on brain surfaces, leading to dorsal repulsion of CST axons; in utero electroporation of Sulf1/2 into radial glial cells rescues the CST defects.","method":"Sulf1/2 double KO mice; in utero electroporation rescue; proteomic analysis; Slit2 protein localization by immunostaining; HS sulfation analysis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo rescue with proteomic identification of molecular substrate (Slit2); mechanistically links HS desulfation to axon guidance molecule presentation","pmids":["29062064"],"is_preprint":false},{"year":2019,"finding":"CRISPR/Cas9 genome-scale knockout screening confirmed SULF1 loss as contributing to cisplatin resistance in ovarian cancer cell lines, validated by CCK-8 and RT-PCR analysis.","method":"Genome-scale CRISPR/Cas9 knockout (GeCKO) screening; CCK-8 viability assay; RT-PCR","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — unbiased genome-wide screen with validation; single lab","pmids":["31218106"],"is_preprint":false},{"year":2020,"finding":"SULF1, produced primarily by bone marrow fibroblasts, suppresses Wnt3A-driven growth of prostate cancer cells in a 3D perlecan-modified triculture model; M2-like macrophages increase SULF1 and HSPG2 levels in fibroblasts, and SULF1 knockout fibroblasts fail to suppress Wnt3A-mediated PCa tumoroid growth.","method":"SULF1 knockout fibroblasts; 3D bone marrow biomimetic hydrogel triculture model; co-culture with macrophages; Wnt3A treatment; tumoroid growth measurement","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR KO in 3D model with defined molecular readout; single lab","pmids":["32413029"],"is_preprint":false},{"year":2024,"finding":"Cancer-associated fibroblast-secreted SULF1 binds to TGFBR3 on gastric cancer cell membranes, interferes with the TGF-β1/TGFBR3 interaction, and subsequently activates TGF-β signaling to promote cancer cell metastasis and cisplatin resistance.","method":"Co-immunoprecipitation; CAF-derived conditioned medium experiments; SULF1 overexpression/knockdown; Western blot for TGF-β pathway components; in vivo xenograft","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP identifying TGFBR3 as binding partner; functional consequences demonstrated; single lab","pmids":["38438372"],"is_preprint":false},{"year":2024,"finding":"SULF1 promotes pulmonary fibrosis by catalyzing the release of TGF-β1 bound to TGFβRIII (TGFBR3), thereby activating the TGF-β1/SMAD pathway; TGF-β1 in turn induces SULF1 expression through the TGF-β1/SMAD pathway, creating a positive feedback loop.","method":"Co-immunoprecipitation; SULF1 shRNA knockdown in HFL1 fibroblasts; Western blot for SMAD pathway; TGF-β1 ELISA; fibroblast functional assays (proliferation, migration, invasion)","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus functional assays in relevant cell type; positive feedback loop defined; single lab","pmids":["39354547"],"is_preprint":false},{"year":2025,"finding":"Active human SULF1 requires co-expression of sulfatase-modifying factor 1 (SUMF1) for full enzymatic activity, which depends on conversion of the active site cysteine to Cα-formylglycine and the presence of a Ca2+ ion; marine fucosylated chondroitin sulfate inhibits SULF1 with IC50 ~0.05 μg/mL in mixed-mode inhibition.","method":"Recombinant protein expression in HEK293 cells; co-expression with SUMF1; enzymatic activity assays; kinetic analysis; inhibitor characterization","journal":"Glycobiology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted enzymatic activity with defined active site chemistry and quantitative inhibition kinetics","pmids":["41025518"],"is_preprint":false},{"year":2025,"finding":"SULF1 interacts with thrombospondin-2 (THBS2) to regulate the TGF-β1/SMAD2/3 pathway in colon cancer; MARCHF1 ubiquitin ligase accelerates SULF1 protein degradation, thereby suppressing SULF1-driven tumor progression and 5-FU resistance.","method":"Co-immunoprecipitation of SULF1 with THBS2; MARCHF1 overexpression/knockdown; Western blot for SMAD2/3; proliferation, migration, and invasion assays; 5-FU sensitivity assay","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP identifying THBS2; MARCHF1 as a degradation mechanism; functional assays; single lab","pmids":["41550717"],"is_preprint":false},{"year":2026,"finding":"Sulf1 disruption in D2-MSNs of the nucleus accumbens shell alters neural firing (smaller rheobase but blunted response to larger current), and in D1-MSNs leads to more depolarized resting membrane potentials and increased AMPA/NMDA ratio, demonstrating that Sulf1 is required for regulation of neuronal excitability and glutamatergic transmission in the adult brain.","method":"Sulf1 knockout mice; whole-cell patch-clamp recording in D1-MSNs and D2-MSNs labeled with Cre-dependent AAV-mCherry","journal":"eNeuro","confidence":"High","confidence_rationale":"Tier 2 — electrophysiology in genetically defined cell types in KO mice; direct cellular mechanism identified","pmids":["41381361"],"is_preprint":false},{"year":2026,"finding":"Sulf1 conditional knockout in D1 receptor-expressing cells impairs cocaine-induced conditioned place preference (reward learning), while Sulf1 conditional knockout in D2 receptor-expressing cells impairs inhibitory avoidance (aversion learning), demonstrating pathway-specific roles of Sulf1 in reward and aversion circuits.","method":"Sulf1 floxed mice generated by CRISPR-Cas9; Cre-mediated conditional KO in D1-Cre and D2-Cre mice; conditioned place preference and inhibitory avoidance behavioral tests","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific conditional KO with double dissociation of behavioral phenotypes; defines pathway specificity","pmids":["41486756"],"is_preprint":false},{"year":2026,"finding":"SULF1 derived from cancer-associated fibroblasts promotes invasion of head and neck squamous cell carcinoma cells; CRISPR/Cas9-mediated SULF1 knockout in primary HNSCC CAFs reduces fibroblast proliferation and markedly impairs cancer cell migration and invasion in 2D and 3D spheroid coculture models; SULF2 expressed in tumor cells does not compensate for SULF1 loss.","method":"CRISPR/Cas9 SULF1 knockout in primary CAFs; 2D migration/invasion assays; 3D spheroid coculture with two-photon microscopy; proteomic analysis","journal":"Cancer medicine","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR KO in primary cells with 3D functional model; single lab","pmids":["41549062"],"is_preprint":false}],"current_model":"SULF1 is a cell surface-associated and secreted heparan sulfate 6-O-endosulfatase that selectively removes 6-O-sulfate groups from trisulfated (N,6-O,2-O) disaccharides in heparan sulfate proteoglycan chains; this desulfation activity—which depends on an active-site Cα-formylglycine (generated by SUMF1), Ca2+, and a unique positively charged hydrophilic domain that binds HS through catch-bond mechanics—reduces the co-receptor function of HSPGs for multiple heparin-binding growth factors (FGF-2, HGF, VEGF165, HB-EGF, GDNF, Wnt ligands, Slit2) by lowering their binding affinity, thereby attenuating downstream RTK, ERK, AKT, Wnt/β-catenin, and SMAD signaling cascades; context-dependently, SULF1 can enhance or suppress specific ligand-receptor interactions (e.g., promoting GDNF signaling by releasing it from HS-sequestration, or restricting Shh gradient diffusion), and in the adult brain it regulates glutamatergic transmission and dopamine-pathway-specific reward/aversion behaviors, while its epigenetic silencing or CAF-specific expression is exploited in cancer to modulate tumor growth, angiogenesis, and drug resistance."},"narrative":{"teleology":[{"year":2003,"claim":"The key question of how HSPG sulfation is enzymatically regulated at the cell surface was answered by identifying HSulf-1 as a 6-O-endosulfatase that desulfates HSPGs and thereby attenuates RTK/ERK signaling downstream of FGF-2 and HB-EGF.","evidence":"Re-expression in ovarian cancer cells with measurement of HSPG sulfation, RTK phosphorylation, and ERK activation","pmids":["12686563"],"confidence":"High","gaps":["Enzymatic specificity for particular HS disaccharide motifs not yet defined","In vivo relevance not established"]},{"year":2004,"claim":"The generality of HSulf-1's signaling suppression was extended beyond FGF/EGFR to HGF/c-Met, establishing that HSPG desulfation broadly dampens HS-dependent growth factor axes including AKT signaling and cell invasion.","evidence":"Stable HSulf-1 transfection in SCCHN cells; Western blot for phospho-c-Met, phospho-ERK, phospho-AKT; transwell invasion","pmids":["14973553"],"confidence":"High","gaps":["Direct evidence for HSPG structural changes mediating c-Met attenuation not shown","Endogenous regulation of SULF1 expression unknown"]},{"year":2005,"claim":"In vivo tumor growth suppression by SULF1/SULF2 was demonstrated, establishing their functional equivalence and anti-tumorigenic role through cell-surface sulfatase activity.","evidence":"Stable transfection in myeloma cells; SCID mouse xenograft","pmids":["16192265"],"confidence":"High","gaps":["Contribution of each sulfatase individually in vivo not resolved","Mechanism of ECM deposition promotion unclear"]},{"year":2006,"claim":"HSulf-1 was shown to regulate angiogenesis by disrupting the ternary FGF-2/FGFR1c/HS complex on endothelial cells, extending its function to the tumor microvasculature and HS-dependent growth factors VEGF165 and HGF.","evidence":"shRNA knockdown in HUVECs; co-IP of FGF-2/FGFR1c/HS; Matrigel plug and xenograft assays","pmids":["16778174"],"confidence":"High","gaps":["Whether anti-angiogenic activity operates through endothelial-autonomous or paracrine mechanisms in vivo not fully distinguished"]},{"year":2007,"claim":"Several foundational questions were resolved simultaneously: Sulf1/Sulf2 double-knockout mice revealed neonatal lethality proving developmental essentiality and functional redundancy; Sulf1 was shown to enhance rather than inhibit GDNF signaling by releasing HS-sequestered ligand; N-glycosylation was identified as essential for enzymatic activity and membrane targeting; SULF1 silencing was attributed to promoter DNA methylation and histone methylation; and HSulf-1 loss was linked to autocrine EGFR-ERK activation via amphiregulin/HB-EGF.","evidence":"Double KO mice with phenotyping; GDNF binding and neurite sprouting in KO tissues; glycosylation mutants and heparin-binding assays; bisulfite sequencing and ChIP; shRNA with neutralizing antibodies in breast cancer cells","pmids":["17593974","17720696","17855356","17310998","17363371"],"confidence":"High","gaps":["Whether single Sulf1 KO has subtle phenotypes masked by Sulf2 compensation remains unclear","Structural basis of N-glycosylation requirement not defined"]},{"year":2009,"claim":"The hydrophilic domain (HD) was established as the HS-binding module with nanomolar affinity essential for enzymatic function; substrate specificity was defined as selective for trisulfated UA2S-GlcNS6S disaccharides; and transcriptional regulation by HNF1β was identified.","evidence":"SPR with HD constructs; disaccharide HPLC analysis; PI-88 inhibitor studies; ChIP and reporter assays for HNF1β binding to SULF1 promoter","pmids":["19666466","19822709","19487294"],"confidence":"High","gaps":["Structural model of HD–HS interaction lacking","Whether PI-88 inhibition is therapeutically relevant in vivo unknown"]},{"year":2011,"claim":"HIF-1α/HIF-2α were identified as direct transcriptional repressors of SULF1 under hypoxia, linking tumor microenvironment oxygen tension to HSPG sulfation state, and SULF1 was shown to inhibit Wnt/β-catenin signaling at the HSPG level upstream of intracellular pathway components.","evidence":"ChIP for HIF binding to SULF1 promoter HREs; Wnt reporter epistasis with Wnt3a rescue and β-catenin knockdown in gastric cancer cells","pmids":["21266348","21722266"],"confidence":"High","gaps":["Whether hypoxic silencing of SULF1 is reversible upon reoxygenation not tested","Wnt ligand specificity of SULF1 inhibition not addressed"]},{"year":2012,"claim":"Organ-specific HS sulfation patterns were shown to be generated by differential Sulf1/Sulf2 activity in vivo, with Sulf1 mRNA levels correlating with tissue-specific HS desulfation.","evidence":"HPLC disaccharide analysis across organs from Sulf1 and Sulf2 KO mice","pmids":["22298771"],"confidence":"High","gaps":["Whether organ-specific sulfation differences translate to differential growth factor responsiveness not tested"]},{"year":2013,"claim":"Sulf1's action on Wnt ligands was shown to be context-dependent: it facilitates Wingless/Wnt degradation by reducing HS binding in Drosophila, and the HD was found to use multiple cooperative HS-binding sites for processive chain editing.","evidence":"Drosophila wing disc Wg stability assays; AFM single-molecule force spectroscopy of HD subdomains","pmids":["23300081","23891937"],"confidence":"High","gaps":["Whether processivity is required in vivo not demonstrated","Crystal structure of HD still unavailable"]},{"year":2014,"claim":"Sulf1 was placed in developmental morphogen gradient control (restricting Shh diffusion in neural tube) and vascular specification (promoting VEGFA165/Notch signaling in arterial fate), while in cancer its loss was shown to suppress Bim expression specifically through ERK pathway activation.","evidence":"Shh gradient imaging in Xenopus morphants; zebrafish morpholino with vegfa165 rescue; ERK/PI3K inhibitor epistasis in ovarian cancer cells","pmids":["24768893","23959107","24596063"],"confidence":"High","gaps":["Whether Sulf1 acts on Shh directly or indirectly through HS-bound intermediates not resolved","In vivo relevance of Bim regulation not confirmed in patient samples"]},{"year":2015,"claim":"The biophysical mechanism of HD–HS interaction was defined as a catch bond dependent on 6-O-sulfation, providing a molecular explanation for how Sulf1 maintains productive engagement with its substrate; Sulf1 was also shown to have ligand-specific effects on Wnt signaling (inhibiting Wnt8a, enhancing Wnt11b) and to regulate cerebellar neuron survival and migration.","evidence":"AFM force-clamp spectroscopy; Wnt8a/Wnt11b signaling and imaging in Xenopus; primary cerebellar granule cells from Sulf1 KO mice","pmids":["25863062","25681501","26448642"],"confidence":"High","gaps":["Whether catch bond mechanism applies to full-length enzyme on cell surfaces not confirmed","Wnt ligand selectivity mechanism not structurally explained"]},{"year":2015,"claim":"SULF1 loss was linked to metabolic reprogramming (Warburg effect) in ovarian cancer through HB-EGF/ERK/c-Myc–driven upregulation of glycolytic enzymes and inhibition of pyruvate dehydrogenase.","evidence":"Isotope tracer metabolomics; oxygen consumption; c-Myc inhibitor epistasis; PG545 treatment","pmids":["26378042"],"confidence":"High","gaps":["Whether metabolic phenotype is reversible upon SULF1 restoration in vivo not tested"]},{"year":2017,"claim":"Sulf1/2-mediated HS desulfation was shown to be required for corticospinal tract axon guidance by controlling Slit2 protein distribution on brain surfaces, with rescue by in utero electroporation.","evidence":"Sulf1/2 double KO mice; Slit2 immunostaining; in utero electroporation rescue","pmids":["29062064"],"confidence":"High","gaps":["Individual contribution of Sulf1 versus Sulf2 to CST guidance not separated"]},{"year":2019,"claim":"Unbiased genome-scale CRISPR screening independently confirmed SULF1 loss as a contributor to cisplatin resistance in ovarian cancer.","evidence":"GeCKO library screen with CCK-8 validation","pmids":["31218106"],"confidence":"Medium","gaps":["Mechanism of resistance beyond prior ERK/Bim findings not defined","Single cell line used"]},{"year":2020,"claim":"SULF1 produced by bone marrow fibroblasts was shown to suppress Wnt3A-driven prostate cancer growth in a 3D biomimetic microenvironment, establishing its paracrine tumor-suppressive function in the stromal compartment.","evidence":"SULF1 KO fibroblasts in 3D perlecan-modified hydrogel triculture; Wnt3A stimulation","pmids":["32413029"],"confidence":"Medium","gaps":["In vivo validation of fibroblast-derived SULF1 tumor suppression lacking","Whether SULF1 acts on perlecan HS specifically not tested"]},{"year":2024,"claim":"A new non-enzymatic function was proposed: CAF-secreted SULF1 physically binds TGFBR3 on cancer cells, interfering with TGF-β1/TGFBR3 interaction and activating TGF-β/SMAD signaling to promote metastasis, with a positive feedback loop identified in pulmonary fibrosis.","evidence":"Co-IP of SULF1–TGFBR3; CAF conditioned medium; SMAD pathway Western blots; in vivo xenograft; fibroblast functional assays","pmids":["38438372","39354547"],"confidence":"Medium","gaps":["Whether the TGFBR3 interaction requires SULF1 enzymatic activity or is independent not tested","Reciprocal IP validation lacking for TGFBR3 interaction","Positive feedback loop not validated in vivo"]},{"year":2025,"claim":"Recombinant human SULF1 was fully reconstituted, confirming SUMF1-dependent Cα-formylglycine formation and Ca²⁺ as catalytic requirements, and a potent marine fucosylated chondroitin sulfate inhibitor was characterized; separately, SULF1–THBS2 interaction was linked to TGF-β1/SMAD2/3 signaling in colon cancer, with MARCHF1 identified as an E3 ligase targeting SULF1 for degradation.","evidence":"Recombinant expression in HEK293 with SUMF1 co-expression; kinetic analysis; Co-IP of SULF1–THBS2; MARCHF1 overexpression/knockdown","pmids":["41025518","41550717"],"confidence":"High","gaps":["No crystal or cryo-EM structure of SULF1 available","MARCHF1-mediated degradation not validated in vivo","Whether fCS inhibitor has therapeutic utility untested"]},{"year":2026,"claim":"Cell-type-specific roles of Sulf1 in the adult brain were established: Sulf1 regulates neuronal excitability and AMPA/NMDA ratios in striatal MSNs, and conditional deletion in D1- versus D2-MSNs produces a double dissociation of reward versus aversion learning; CAF-derived SULF1 was also shown to non-redundantly promote HNSCC invasion.","evidence":"Whole-cell patch clamp in D1/D2-MSNs of Sulf1 KO mice; conditional KO with behavioral testing; CRISPR KO in primary CAFs with 3D spheroid coculture","pmids":["41381361","41486756","41549062"],"confidence":"High","gaps":["Whether Sulf1 acts on synaptic HS to regulate glutamate receptor clustering or on growth factor signaling in neurons not distinguished","Molecular targets of Sulf1 in striatal circuits unidentified"]},{"year":null,"claim":"Despite extensive functional characterization, no atomic-resolution structure of SULF1 exists, the precise mechanism by which HD-mediated catch-bond processivity operates on native cell-surface HS remains unresolved, and whether the newly described protein–protein interactions (TGFBR3, THBS2) are enzymatic-activity-dependent or represent independent binding functions is unknown.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal or cryo-EM structure","Catch-bond processivity not demonstrated on native cell surfaces","Enzymatic versus non-enzymatic contributions to TGFBR3/THBS2 interactions unresolved","Neuronal substrates and HS-binding partners in brain circuits unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,10,17,34]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,10,17]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,6,9]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[2,32,38]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[2,29]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,7,14,16,21,28]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,5,22,23,24]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[29,36,37]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[10,17,28]}],"complexes":[],"partners":["TGFBR3","THBS2","SUMF1","MARCHF1"],"other_free_text":[]},"mechanistic_narrative":"SULF1 is a cell-surface and secreted heparan sulfate 6-O-endosulfatase that selectively removes 6-O-sulfate groups from trisulfated disaccharide units within heparan sulfate proteoglycan (HSPG) chains, thereby remodeling the sulfation code that governs growth factor–HSPG co-receptor interactions and downstream signaling. Its catalytic activity requires SUMF1-mediated conversion of the active-site cysteine to Cα-formylglycine, Ca²⁺, and N-linked glycosylation, while a unique positively charged hydrophilic domain mediates high-affinity, catch-bond-dependent engagement with HS substrate [PMID:41025518, PMID:25863062, PMID:17855356, PMID:19666466]. By desulfating HSPGs, SULF1 diminishes HS-dependent co-receptor function for FGF-2, HGF, HB-EGF, VEGF165, and Wnt ligands, attenuating RTK, ERK, AKT, and Wnt/β-catenin signaling cascades; conversely, it can enhance GDNF signaling by releasing HS-sequestered ligand and restricts Shh morphogen gradient diffusion [PMID:12686563, PMID:14973553, PMID:16778174, PMID:17720696, PMID:24768893, PMID:21722266]. Beyond development—where Sulf1/Sulf2 double knockouts exhibit neonatal lethality with skeletal and renal defects—SULF1 regulates glutamatergic transmission and dopamine-pathway-specific reward and aversion behaviors in the adult brain, and its epigenetic silencing or cancer-associated fibroblast-restricted expression modulates tumor growth, angiogenesis, metabolic reprogramming, and chemoresistance [PMID:17593974, PMID:41381361, PMID:41486756, PMID:17310998, PMID:26378042, PMID:41549062]."},"prefetch_data":{"uniprot":{"accession":"Q8IWU6","full_name":"Extracellular sulfatase Sulf-1","aliases":["Arylsulfatase","N-acetylglucosamine-6-sulfatase"],"length_aa":871,"mass_kda":101.0,"function":"Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity (PubMed:12368295, PubMed:12686563). It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin (PubMed:12368295, PubMed:12686563). Diminishes HSPG (heparan sulfate proteoglycans) sulfation, inhibits signaling by heparin-dependent growth factors, diminishes proliferation, and facilitates apoptosis in response to exogenous stimulation (PubMed:12686563)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q8IWU6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SULF1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SULF1","total_profiled":1310},"omim":[{"mim_id":"621228","title":"LONG INTERGENIC NONCODING RNA 1013; LINC01013","url":"https://www.omim.org/entry/621228"},{"mim_id":"613543","title":"SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 5A1; SLCO5A1","url":"https://www.omim.org/entry/613543"},{"mim_id":"610013","title":"SULFATASE 2; SULF2","url":"https://www.omim.org/entry/610013"},{"mim_id":"610012","title":"SULFATASE 1; SULF1","url":"https://www.omim.org/entry/610012"},{"mim_id":"607102","title":"WT1 TRANSCRIPTION FACTOR; WT1","url":"https://www.omim.org/entry/607102"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":112.2}],"url":"https://www.proteinatlas.org/search/SULF1"},"hgnc":{"alias_symbol":["KIAA1077","SULF-1","hSulf-1"],"prev_symbol":[]},"alphafold":{"accession":"Q8IWU6","domains":[{"cath_id":"3.40.720.10","chopping":"40-391_407-414","consensus_level":"high","plddt":95.3084,"start":40,"end":414},{"cath_id":"-","chopping":"775-832","consensus_level":"medium","plddt":95.0052,"start":775,"end":832}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IWU6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IWU6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IWU6-F1-predicted_aligned_error_v6.png","plddt_mean":74.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SULF1","jax_strain_url":"https://www.jax.org/strain/search?query=SULF1"},"sequence":{"accession":"Q8IWU6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IWU6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IWU6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IWU6"}},"corpus_meta":[{"pmid":"12686563","id":"PMC_12686563","title":"Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12686563","citation_count":204,"is_preprint":false},{"pmid":"23684551","id":"PMC_23684551","title":"MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.","date":"2013","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/23684551","citation_count":159,"is_preprint":false},{"pmid":"17720696","id":"PMC_17720696","title":"SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17720696","citation_count":144,"is_preprint":false},{"pmid":"16778174","id":"PMC_16778174","title":"HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16778174","citation_count":121,"is_preprint":false},{"pmid":"16192265","id":"PMC_16192265","title":"HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16192265","citation_count":117,"is_preprint":false},{"pmid":"14973553","id":"PMC_14973553","title":"HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14973553","citation_count":117,"is_preprint":false},{"pmid":"17593974","id":"PMC_17593974","title":"Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17593974","citation_count":101,"is_preprint":false},{"pmid":"17310998","id":"PMC_17310998","title":"Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17310998","citation_count":93,"is_preprint":false},{"pmid":"19373441","id":"PMC_19373441","title":"The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis.","date":"2009","source":"Journal of gastrointestinal cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19373441","citation_count":80,"is_preprint":false},{"pmid":"15817123","id":"PMC_15817123","title":"Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.","date":"2005","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15817123","citation_count":78,"is_preprint":false},{"pmid":"18213582","id":"PMC_18213582","title":"Redundant function of the heparan sulfate 6-O-endosulfatases Sulf1 and Sulf2 during skeletal development.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18213582","citation_count":77,"is_preprint":false},{"pmid":"19822709","id":"PMC_19822709","title":"Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88.","date":"2009","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/19822709","citation_count":75,"is_preprint":false},{"pmid":"22298771","id":"PMC_22298771","title":"Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22298771","citation_count":71,"is_preprint":false},{"pmid":"19666466","id":"PMC_19666466","title":"Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19666466","citation_count":65,"is_preprint":false},{"pmid":"17363371","id":"PMC_17363371","title":"Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17363371","citation_count":64,"is_preprint":false},{"pmid":"16762634","id":"PMC_16762634","title":"SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.","date":"2006","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/16762634","citation_count":63,"is_preprint":false},{"pmid":"21228115","id":"PMC_21228115","title":"Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.","date":"2011","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21228115","citation_count":59,"is_preprint":false},{"pmid":"18507859","id":"PMC_18507859","title":"Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage.","date":"2008","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18507859","citation_count":54,"is_preprint":false},{"pmid":"21266348","id":"PMC_21266348","title":"HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21266348","citation_count":50,"is_preprint":false},{"pmid":"19006069","id":"PMC_19006069","title":"Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer.","date":"2009","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19006069","citation_count":43,"is_preprint":false},{"pmid":"20602915","id":"PMC_20602915","title":"Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20602915","citation_count":42,"is_preprint":false},{"pmid":"26448642","id":"PMC_26448642","title":"Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26448642","citation_count":41,"is_preprint":false},{"pmid":"19487294","id":"PMC_19487294","title":"Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19487294","citation_count":39,"is_preprint":false},{"pmid":"31218106","id":"PMC_31218106","title":"Loss of ZNF587B and SULF1 contributed to cisplatin resistance in ovarian cancer cell lines based on Genome-scale CRISPR/Cas9 screening.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31218106","citation_count":37,"is_preprint":false},{"pmid":"19577565","id":"PMC_19577565","title":"A novel SULF1 splice variant inhibits Wnt signalling but enhances angiogenesis by opposing SULF1 activity.","date":"2009","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19577565","citation_count":33,"is_preprint":false},{"pmid":"16603650","id":"PMC_16603650","title":"Hsulf-1 regulates growth and invasion of pancreatic cancer cells.","date":"2006","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16603650","citation_count":30,"is_preprint":false},{"pmid":"22873647","id":"PMC_22873647","title":"HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells.","date":"2012","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/22873647","citation_count":30,"is_preprint":false},{"pmid":"25225614","id":"PMC_25225614","title":"Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer.","date":"2014","source":"Cancer & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25225614","citation_count":29,"is_preprint":false},{"pmid":"17855356","id":"PMC_17855356","title":"Quail Sulf1 function requires asparagine-linked glycosylation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17855356","citation_count":28,"is_preprint":false},{"pmid":"26378042","id":"PMC_26378042","title":"HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26378042","citation_count":26,"is_preprint":false},{"pmid":"21722266","id":"PMC_21722266","title":"HSulf-1 inhibits cell proliferation and invasion in human gastric cancer.","date":"2011","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/21722266","citation_count":26,"is_preprint":false},{"pmid":"17061267","id":"PMC_17061267","title":"Sulf1 expression pattern and its role in cartilage and joint development.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17061267","citation_count":26,"is_preprint":false},{"pmid":"32432744","id":"PMC_32432744","title":"LncRNA NEAT1 regulated cell proliferation, invasion, migration and apoptosis by targeting has-miR-376b-3p/SULF1 axis in non-small cell lung cancer.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32432744","citation_count":26,"is_preprint":false},{"pmid":"21853101","id":"PMC_21853101","title":"hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21853101","citation_count":24,"is_preprint":false},{"pmid":"23300081","id":"PMC_23300081","title":"Drosophila heparan sulfate 6-O-endosulfatase Sulf1 facilitates wingless (Wg) protein degradation.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23300081","citation_count":24,"is_preprint":false},{"pmid":"25681501","id":"PMC_25681501","title":"Sulf1 has ligand-dependent effects on canonical and non-canonical Wnt signalling.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25681501","citation_count":22,"is_preprint":false},{"pmid":"22700218","id":"PMC_22700218","title":"Mammalian Sulf1 RNA alternative splicing and its significance to tumour growth regulation.","date":"2012","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22700218","citation_count":22,"is_preprint":false},{"pmid":"23583585","id":"PMC_23583585","title":"Sulf1 modulates BMP signaling and is required for somite morphogenesis and development of the horizontal myoseptum.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23583585","citation_count":22,"is_preprint":false},{"pmid":"26764203","id":"PMC_26764203","title":"Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling.","date":"2016","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26764203","citation_count":22,"is_preprint":false},{"pmid":"27888216","id":"PMC_27888216","title":"Drosophila Sulf1 is required for the termination of intestinal stem cell division during regeneration.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27888216","citation_count":22,"is_preprint":false},{"pmid":"32413029","id":"PMC_32413029","title":"SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32413029","citation_count":22,"is_preprint":false},{"pmid":"24768893","id":"PMC_24768893","title":"Sulf1 influences the Shh morphogen gradient during the dorsal ventral patterning of the neural tube in Xenopus tropicalis.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24768893","citation_count":22,"is_preprint":false},{"pmid":"22825572","id":"PMC_22825572","title":"The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22825572","citation_count":21,"is_preprint":false},{"pmid":"25863062","id":"PMC_25863062","title":"Catch bond interaction between cell-surface sulfatase Sulf1 and glycosaminoglycans.","date":"2015","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/25863062","citation_count":21,"is_preprint":false},{"pmid":"21214932","id":"PMC_21214932","title":"Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer.","date":"2011","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/21214932","citation_count":21,"is_preprint":false},{"pmid":"26464246","id":"PMC_26464246","title":"Expression of Sulf1 and Sulf2 in cartilage, bone and endochondral fracture healing.","date":"2015","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26464246","citation_count":21,"is_preprint":false},{"pmid":"36428645","id":"PMC_36428645","title":"Extracellular Heparan 6-O-Endosulfatases SULF1 and SULF2 in Head and Neck Squamous Cell Carcinoma and Other Malignancies.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36428645","citation_count":21,"is_preprint":false},{"pmid":"38438372","id":"PMC_38438372","title":"Cancer associated fibroblasts-derived SULF1 promotes gastric cancer metastasis and CDDP resistance through the TGFBR3-mediated TGF-β signaling pathway.","date":"2024","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38438372","citation_count":20,"is_preprint":false},{"pmid":"25448158","id":"PMC_25448158","title":"Sulf1 and Sulf2 expression in the nervous system and its role in limiting neurite outgrowth in vitro.","date":"2014","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25448158","citation_count":18,"is_preprint":false},{"pmid":"24726914","id":"PMC_24726914","title":"SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression.","date":"2014","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/24726914","citation_count":18,"is_preprint":false},{"pmid":"29062064","id":"PMC_29062064","title":"Desulfation of Heparan Sulfate by Sulf1 and Sulf2 Is Required for Corticospinal Tract Formation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29062064","citation_count":17,"is_preprint":false},{"pmid":"23074159","id":"PMC_23074159","title":"Distinct expression patterns of Sulf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate development.","date":"2012","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/23074159","citation_count":16,"is_preprint":false},{"pmid":"27013228","id":"PMC_27013228","title":"SULF1/SULF2 reactivation during liver damage and tumour growth.","date":"2016","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27013228","citation_count":16,"is_preprint":false},{"pmid":"38760544","id":"PMC_38760544","title":"CircNSD1 promotes cardiac fibrosis through targeting the miR-429-3p/SULF1/Wnt/β-catenin signaling pathway.","date":"2024","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/38760544","citation_count":16,"is_preprint":false},{"pmid":"24596063","id":"PMC_24596063","title":"Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24596063","citation_count":16,"is_preprint":false},{"pmid":"28169314","id":"PMC_28169314","title":"Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28169314","citation_count":15,"is_preprint":false},{"pmid":"23959107","id":"PMC_23959107","title":"The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity.","date":"2014","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23959107","citation_count":15,"is_preprint":false},{"pmid":"24970807","id":"PMC_24970807","title":"Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24970807","citation_count":15,"is_preprint":false},{"pmid":"22086394","id":"PMC_22086394","title":"Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.","date":"2011","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22086394","citation_count":13,"is_preprint":false},{"pmid":"23891937","id":"PMC_23891937","title":"Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23891937","citation_count":13,"is_preprint":false},{"pmid":"27693418","id":"PMC_27693418","title":"Tumour-necrosis factor-α induces heparan sulfate 6-O-endosulfatase 1 (Sulf-1) expression in fibroblasts.","date":"2016","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27693418","citation_count":13,"is_preprint":false},{"pmid":"24322345","id":"PMC_24322345","title":"The association of arylendosulfatase 1 (SULF1) gene polymorphism with recurrent miscarriage.","date":"2013","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24322345","citation_count":12,"is_preprint":false},{"pmid":"32377705","id":"PMC_32377705","title":"HSulf‑1 and palbociclib exert synergistic antitumor effects on RB‑positive triple‑negative breast cancer.","date":"2020","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32377705","citation_count":12,"is_preprint":false},{"pmid":"23053899","id":"PMC_23053899","title":"SULF1 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells by decreasing heparin-binding growth factor signaling.","date":"2012","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23053899","citation_count":11,"is_preprint":false},{"pmid":"30127996","id":"PMC_30127996","title":"Genetic variations in the SULF1 gene alter the risk of cervical cancer and precancerous lesions.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30127996","citation_count":11,"is_preprint":false},{"pmid":"25370455","id":"PMC_25370455","title":"Expression of the heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, in the avian and mammalian inner ear suggests a role for sulfation during inner ear development.","date":"2014","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/25370455","citation_count":11,"is_preprint":false},{"pmid":"27294358","id":"PMC_27294358","title":"Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling.","date":"2016","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27294358","citation_count":11,"is_preprint":false},{"pmid":"22848304","id":"PMC_22848304","title":"HSulf-1 suppresses cell growth and down-regulates Hedgehog signaling in human gastric cancer cells.","date":"2011","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/22848304","citation_count":10,"is_preprint":false},{"pmid":"39354547","id":"PMC_39354547","title":"SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39354547","citation_count":9,"is_preprint":false},{"pmid":"23480519","id":"PMC_23480519","title":"Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.","date":"2013","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/23480519","citation_count":9,"is_preprint":false},{"pmid":"32038163","id":"PMC_32038163","title":"Abnormal Pyramidal Decussation and Bilateral Projection of the Corticospinal Tract Axons in Mice Lacking the Heparan Sulfate Endosulfatases, Sulf1 and Sulf2.","date":"2020","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32038163","citation_count":9,"is_preprint":false},{"pmid":"26236329","id":"PMC_26236329","title":"Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis.","date":"2015","source":"Medical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/26236329","citation_count":8,"is_preprint":false},{"pmid":"38844922","id":"PMC_38844922","title":"SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling.","date":"2024","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/38844922","citation_count":8,"is_preprint":false},{"pmid":"33276062","id":"PMC_33276062","title":"Development of novel monoclonal antibodies and immunoassays for sensitive and specific detection of SULF1 endosulfatase.","date":"2020","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/33276062","citation_count":7,"is_preprint":false},{"pmid":"17905233","id":"PMC_17905233","title":"FGF mediated Sulf1 regulation.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17905233","citation_count":7,"is_preprint":false},{"pmid":"24911625","id":"PMC_24911625","title":"Association of the SNP rs2623047 in the HSPG modification enzyme SULF1 with an Australian Caucasian breast cancer cohort.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24911625","citation_count":7,"is_preprint":false},{"pmid":"27274271","id":"PMC_27274271","title":"Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study.","date":"2016","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27274271","citation_count":7,"is_preprint":false},{"pmid":"37539927","id":"PMC_37539927","title":"SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer.","date":"2024","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/37539927","citation_count":6,"is_preprint":false},{"pmid":"35409127","id":"PMC_35409127","title":"Context Dependent Sulf1/Sulf2 Functional Divergence in Endothelial Cell Activity.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35409127","citation_count":6,"is_preprint":false},{"pmid":"19653319","id":"PMC_19653319","title":"Expression analysis of Sulf1 in the chick forebrain at early and late stages of development.","date":"2009","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/19653319","citation_count":5,"is_preprint":false},{"pmid":"31428635","id":"PMC_31428635","title":"Sulfatases, in Particular Sulf1, Are Important for the Integrity of the Glomerular Filtration Barrier in Zebrafish.","date":"2019","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/31428635","citation_count":5,"is_preprint":false},{"pmid":"24944651","id":"PMC_24944651","title":"hSulf-1 inhibits cell proliferation and migration and promotes apoptosis by suppressing stat3 signaling in hepatocellular carcinoma.","date":"2014","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/24944651","citation_count":5,"is_preprint":false},{"pmid":"29360432","id":"PMC_29360432","title":"Multi-tasking Sulf1/Sulf2 enzymes do not only facilitate extracellular cell signalling but also participate in cell cycle related nuclear events.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29360432","citation_count":4,"is_preprint":false},{"pmid":"37985153","id":"PMC_37985153","title":"[Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis
and Lung Adenocarcinoma].","date":"2023","source":"Zhongguo fei ai za zhi = Chinese journal of lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37985153","citation_count":3,"is_preprint":false},{"pmid":"34489650","id":"PMC_34489650","title":"Expression of Heparan Sulfate Endosulfatases in the Adult Mouse Brain: Co-expression of Sulf1 and Dopamine D1/D2 Receptors.","date":"2021","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/34489650","citation_count":3,"is_preprint":false},{"pmid":"36359323","id":"PMC_36359323","title":"Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/36359323","citation_count":2,"is_preprint":false},{"pmid":"26131010","id":"PMC_26131010","title":"SULF 1 gene polymorphism, rs6990375 is in significant association with fetus failure in IVF technique.","date":"2015","source":"Iranian journal of reproductive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26131010","citation_count":2,"is_preprint":false},{"pmid":"41549062","id":"PMC_41549062","title":"SULF1 in Cancer Associated Fibroblasts Promotes Invasion in Head and Neck Cancer Cell Lines.","date":"2026","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41549062","citation_count":1,"is_preprint":false},{"pmid":"41381361","id":"PMC_41381361","title":"Altered Excitability and Glutamatergic Synaptic Transmission in the Medium Spiny Neurons of the Nucleus Accumbens in Mice Deficient in the Heparan Sulfate Endosulfatase Sulf1.","date":"2026","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/41381361","citation_count":1,"is_preprint":false},{"pmid":"41486756","id":"PMC_41486756","title":"Essential Roles of Heparan Sulfate Endosulfatase Sulf1 in Reward and Aversion Learning Through Distinct Dopamine D1 and D2 Receptor Pathways in Male Mice.","date":"2026","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41486756","citation_count":1,"is_preprint":false},{"pmid":"41025518","id":"PMC_41025518","title":"Production and inhibition of human Heparan 6-O-Endosulfatase SULF1.","date":"2025","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/41025518","citation_count":0,"is_preprint":false},{"pmid":"39707607","id":"PMC_39707607","title":"Genetic variants of FER and SULF1 in the fibroblast-related genes are associated with non-small-cell lung cancer survival.","date":"2024","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39707607","citation_count":0,"is_preprint":false},{"pmid":"38992676","id":"PMC_38992676","title":"Mesomelia-synostoses syndrome: contiguous deletion syndrome, SULF1 haploinsufficiency or enhancer adoption?","date":"2024","source":"Molecular cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/38992676","citation_count":0,"is_preprint":false},{"pmid":"41986482","id":"PMC_41986482","title":"Secreted SULF1 protein modulates CD8 + T cell exhaustion by promoting TAM polarization in gastric cancer.","date":"2026","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/41986482","citation_count":0,"is_preprint":false},{"pmid":"41918590","id":"PMC_41918590","title":"SULF1 and EPB41L3: Potential Biomarkers of Acute Myocardial Infarction and the Vascular Inflammatory Milieu.","date":"2026","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/41918590","citation_count":0,"is_preprint":false},{"pmid":"41205056","id":"PMC_41205056","title":"DCN, NPM3 and SULF1 are hub genes related to vasculogenic mimicry in lung adenocarcinoma.","date":"2025","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41205056","citation_count":0,"is_preprint":false},{"pmid":"41426245","id":"PMC_41426245","title":"SULF1's Role in Endothelial Senescence and Atherosclerosis: Insights from Single-Cell and Bulk Transcriptomics.","date":"2025","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/41426245","citation_count":0,"is_preprint":false},{"pmid":"41550717","id":"PMC_41550717","title":"MARCHF1-mediated SULF1 degradation blocks THBS2/TGF-β/SMAD2/3 signaling to reverse colon cancer metastasis and 5-FU resistance.","date":"2025","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/41550717","citation_count":0,"is_preprint":false},{"pmid":"41376260","id":"PMC_41376260","title":"Circulating miR-378a-3p Screens End-Stage Renal Disease Patients, Predicts the Occurrence of MACEs, and Regulates Vascular Calcification via Targeting SULF1.","date":"2025","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/41376260","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.25.25333715","title":"Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer","date":"2025-08-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.25.25333715","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53308,"output_tokens":9327,"usd":0.149915},"stage2":{"model":"claude-opus-4-6","input_tokens":13282,"output_tokens":4808,"usd":0.279915},"total_usd":0.42983,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"HSulf-1 is a cell surface-associated heparan sulfate 6-O-endosulfatase that removes 6-O-sulfate groups from cell surface HSPGs, thereby diminishing phosphorylation of receptor tyrosine kinases (including FGFR and EGFR family members) that require sulfated HSPGs as co-receptors, and attenuating downstream ERK signaling in response to FGF-2 and HB-EGF.\",\n      \"method\": \"Re-expression of HSulf-1 in ovarian cancer cell lines; measurement of HSPG sulfation, RTK phosphorylation, and ERK pathway activation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain-of-function with multiple orthogonal readouts (sulfation, phosphorylation, signaling, proliferation, apoptosis); foundational paper replicated broadly\",\n      \"pmids\": [\"12686563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HSulf-1 re-expression attenuates HGF-mediated phosphorylation of c-Met and downstream ERK/MAPK and Akt signaling, and reduces HGF-mediated cell motility and invasion in head and neck squamous carcinoma cells.\",\n      \"method\": \"Stable transfection of HSulf-1 in SCCHN cell lines; transwell invasion assay; Western blot for phospho-c-Met, phospho-ERK, phospho-Akt\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function with multiple orthogonal mechanistic readouts; replicated the HSPG-co-receptor mechanism for a new growth factor axis\",\n      \"pmids\": [\"14973553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HSulf-1 and HSulf-2 have similar in vivo functions; their extracellular sulfatase activity is restricted to the local tumor cell surface, and their expression promotes extracellular matrix deposition within tumors while dramatically reducing myeloma tumor growth in SCID mice.\",\n      \"method\": \"Stable transfection of myeloma cells with HSulf-1 or HSulf-2 cDNA; in vivo SCID mouse xenograft model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo loss/gain-of-function with clear cellular and molecular phenotypes; independently replicated functional equivalence\",\n      \"pmids\": [\"16192265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HSulf-1 expression in breast carcinoma cells inhibits angiogenesis in vivo by reducing the ability of vascular endothelial cell heparan sulfate to form a complex with FGF-2 and its receptor FGFR1c; shRNA knockdown of HSulf-1 in HUVECs enhances proliferation mediated by HS-dependent growth factors (FGF-2, HGF, VEGF165) but not HS-independent VEGF121.\",\n      \"method\": \"shRNA knockdown; Matrigel plug assay; CD31 staining; co-immunoprecipitation of FGF-2/FGFR1c/heparan sulfate complex; xenograft model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including co-immunoprecipitation and in vivo data; mechanistically specific to HS-dependent signaling\",\n      \"pmids\": [\"16778174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SULF1 and SULF2 act as major regulators of heparan sulfate 6-O-desulfation in vivo; they reduce GDNF binding to HS and enhance GDNF signaling and neurite sprouting, functioning as essential regulators of GDNF-dependent neural innervation in the embryonic esophagus.\",\n      \"method\": \"Sulf1/Sulf2 double-knockout mice; biochemical HS sulfation analysis; GDNF binding assays; neurite sprouting assays; genetic epistasis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo knockout with biochemical and cell signaling validation; first in vivo evidence for Sulf regulation of specific growth factor signaling\",\n      \"pmids\": [\"17720696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sulf1 and Sulf2 play overlapping yet critical roles in mouse development; neither single knockout showed significant flaws, but Sulf1/Sulf2 double knockout mice exhibited highly penetrant neonatal lethality with skeletal and renal abnormalities, demonstrating functional redundancy.\",\n      \"method\": \"Genetic knockout mice (Sulf1-/-, Sulf2-/-, double KO); phenotypic analysis of development and survival\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double KO with clear survival phenotype; strong genetic evidence for functional redundancy\",\n      \"pmids\": [\"17593974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Quail Sulf1 is an asparagine-linked glycosylated protein; N-linked glycosylation at sites in the enzymatic and C-terminal domains is essential for its enzymatic activity, membrane targeting, secretion, heparin binding, and 6-O-desulfation activity.\",\n      \"method\": \"Domain mapping with deletion mutants; glycosylation inhibitor studies; N-glycanase cleavage; heparin binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assays plus mutagenesis/domain analysis; identifies essential post-translational modification for function\",\n      \"pmids\": [\"17855356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSulf-1 loss in breast cancer cells triggers autocrine activation of the EGFR-ERK pathway through heparin-binding growth factors amphiregulin and HB-EGF; HSulf-1 inhibits this autocrine loop, reducing cyclin D1 levels and altering cell cycle distribution.\",\n      \"method\": \"shRNA-mediated HSulf-1 knockdown; neutralizing antibodies against amphiregulin and HB-EGF; Western blot for phospho-ERK, cyclin D1; cell cycle analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods identifying specific autocrine ligands; reciprocal KD and rescue experiments\",\n      \"pmids\": [\"17363371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSulf-1 expression is epigenetically silenced in ovarian cancer through DNA methylation of CpG sites in exon 1A and histone H3 methylation at the promoter; 5-aza-2'-deoxycytidine treatment restores HSulf-1 transcription.\",\n      \"method\": \"Bisulfite sequencing; chromatin immunoprecipitation (ChIP) for histone H3 methylation; 5-aza-2'-deoxycytidine treatment\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — bisulfite sequencing plus ChIP with functional restoration experiment\",\n      \"pmids\": [\"17310998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The unique hydrophilic domain (HD) of Sulf1 (~320 amino acids, positively charged) is required for enzymatic activity and functions as a high-affinity heparin/heparan sulfate interaction domain with nanomolar affinity; the outer regions of the HD mediate HS binding, and substrate 6-O-sulfate groups are required for association, suggesting that substrate turnover facilitates enzyme release.\",\n      \"method\": \"HD deletion mutants; GST-HD fusion proteins; surface plasmon resonance; heparinase treatment; FGF-2 signaling assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with domain mutants, surface plasmon resonance quantification, and functional signaling readout\",\n      \"pmids\": [\"19666466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSulf-1 and HSulf-2 selectively remove 6-O-sulfate groups from N,6-O,2-O trisulfated disaccharides in intact heparan sulfate on the cell surface; both Sulf activities are potently inhibited by the sulfated heparin mimetic PI-88.\",\n      \"method\": \"Flow cytometry with anti-HS antibody RB4CD12; disaccharide analysis by HPLC; ELISA with purified recombinant enzymes; in vivo activity on brain microvessels\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic characterization with multiple substrates and inhibitor testing\",\n      \"pmids\": [\"19822709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Variant hepatic nuclear factor 1 (vHNF1/HNF1β) is a transcriptional repressor of HSulf-1 in ovarian cancer; vHNF1 binds to two responsive elements in the HSulf-1 promoter and suppresses its expression, reducing sensitivity to cisplatin.\",\n      \"method\": \"shRNA knockdown of vHNF1; reporter assay; chromatin immunoprecipitation (ChIP); xenograft model with cisplatin treatment\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus reporter assay plus functional rescue; identifies specific transcriptional repressor\",\n      \"pmids\": [\"19487294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Promoter hypermethylation of the HSulf-1 gene's 5' regulatory region (approximately 400 bp) correlates with HSulf-1 silencing in human breast and gastric cancer cell lines and tissue samples.\",\n      \"method\": \"Cloning of 5' promoter region; bisulfite sequencing; correlation of methylation with expression\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct bisulfite sequencing with expression correlation; single lab\",\n      \"pmids\": [\"19006069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A novel shorter SULF1 splice variant (SULF1B) antagonizes the canonical SULF1A: while SULF1A enhances Wnt signalling, SULF1B inhibits Wnt signalling and promotes angiogenesis, with both isoforms expressed in a developmental stage-specific manner.\",\n      \"method\": \"Cloning and expression of SULF1 splice variants; Wnt signaling reporter assays; angiogenesis assays; expression analysis in developing tissues\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional assays identifying opposing activities; single lab with multiple readouts\",\n      \"pmids\": [\"19577565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HSulf-1 inhibits autocrine EGFR-ERK signaling through heparin-binding growth factors in breast cancer cells; HSulf-1 expression is transcriptionally repressed under hypoxia via HIF-1α and HIF-2α binding to two functional hypoxia-responsive elements on the native HSulf-1 promoter.\",\n      \"method\": \"HIF-1α knockdown; chromatin immunoprecipitation with HIF-1α and HIF-2α antibodies; shRNA depletion; bFGF2 signaling assays; invasion assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP confirming direct HIF binding to native promoter plus functional rescue; identifies specific transcriptional regulatory mechanism\",\n      \"pmids\": [\"21266348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HSulf-1 re-expression downregulates VEGFR-2 phosphorylation in ovarian and hepatocellular cancer cells, suppressing angiogenesis; shRNA knockdown of HSulf-1 enhances phospho-VEGFR-2 recovery.\",\n      \"method\": \"HSulf-1 expression vectors and shRNA; Western blot for phospho-VEGFR-2; xenograft tumor model; microvessel density analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain and loss of function with phosphorylation readout; single lab\",\n      \"pmids\": [\"21853101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HSulf-1 inhibits Wnt/β-catenin signaling at the cell surface in gastric cancer cells that depend on extracellular Wnt signaling (MKN28), but has no effect in cells with constitutively active intracellular Wnt pathway (AGS), demonstrating that Sulf1 modulates Wnt signaling upstream at the HSPG level.\",\n      \"method\": \"HSulf-1 transfection; Wnt/β-catenin reporter assay; Wnt3a cDNA rescue; β-catenin shRNA; HSPG epitope analysis\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis experiment with Wnt3a rescue and β-catenin knockdown defining pathway position; multiple orthogonal approaches\",\n      \"pmids\": [\"21722266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Sulf1 and Sulf2 differentially generate organ-specific sulfation patterns of heparan sulfate in vivo; Sulf1 predominantly acts on UA2S-GlcNS6S trisulfated disaccharides, and Sulf1 mRNA expression levels in different organs correlate with the degree of HS desulfation in those organs.\",\n      \"method\": \"Disaccharide analysis of heparan sulfate from Sulf1 and Sulf2 knockout mice by HPLC; organ-specific expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical substrate analysis in knockout animals across multiple organs\",\n      \"pmids\": [\"22298771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Sulf1 (and human Sulf1 expressed in Drosophila) inhibits the binding of Wingless/Wnt to Dally (an HSPG), reduces extracellular Wg protein levels by facilitating Wg degradation, and negatively regulates Wg/Wnt signaling; the fate of Wnt ligands upon Sulf action is context-dependent.\",\n      \"method\": \"In vitro, in vivo, and ex vivo systems in Drosophila; HS-Wg interaction assays; Wg stability measurement; human Sulf1 expression in Drosophila wing disc\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple complementary systems (in vitro, in vivo, ex vivo) with mechanistic dissection of Wnt ligand fate\",\n      \"pmids\": [\"23300081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The hydrophilic domain (HD) of Sulf1 contains at least two separate HS-binding sites (inner and C-terminal regions) that cooperate for processive enzymatic action along HS chains; full-length Sulf1 shows broader GAG interaction while HD alone is highly specific for HS/heparin containing 6-O-sulfate substrate groups.\",\n      \"method\": \"Affinity chromatography; AFM single-molecule force spectroscopy; immunofluorescence on living cells; HD subdomain constructs\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-molecule biophysics plus domain mapping; mechanistically resolves HD subdomain contributions\",\n      \"pmids\": [\"23891937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TNF-α induces Sulf-1 expression in fibroblasts via NF-κB, ERK1/2, and p38 MAPK signaling, leading to 6-O-desulfation of cell surface HS and attenuation of FGF-1-mediated ERK1/2 activation and cell proliferation; siRNA silencing of Sulf-1 restores FGF-1 responsiveness.\",\n      \"method\": \"TNF-α treatment of MRC-5 fibroblasts; HS compositional analysis; siRNA knockdown; ERK1/2 activation assay; proliferation assay\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA rescue with biochemical and functional readouts; single lab\",\n      \"pmids\": [\"27693418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of HSulf-1 promotes tumorigenicity in ovarian cancer by decreasing Bim (pro-apoptotic) expression through increased p-ERK; ERK inhibition with PD98059 restores Bim levels, while PI3K/AKT inhibition does not, placing HSulf-1's effect on Bim specifically in the ERK pathway.\",\n      \"method\": \"shRNA knockdown; re-expression constructs; pharmacological inhibitors (PD98059, LY294002); Western blot for Bim; soft agar colony assay; xenograft model\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via pathway-specific inhibitors; reciprocal rescue; in vivo validation\",\n      \"pmids\": [\"24596063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sulf1 modulates BMP and FGF signaling during zebrafish trunk development: sulf1 knockdown decreases Pax7-expressing dermomyotome cells and sdf1/cxcl12 expression, both of which are restored by BMP signaling inhibition, while FGF signaling activation rescues neuromast deposition.\",\n      \"method\": \"Antisense morpholino knockdown in zebrafish; pharmacological inhibition/activation of BMP and FGF; in situ hybridization for pathway markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via pharmacological inhibitors with specific pathway placement; multiple developmental readouts\",\n      \"pmids\": [\"23583585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sulf1 restricts Shh ligand diffusion in the Xenopus neural tube by promoting ventral accumulation of Shh protein; Sulf1 knockdown leads to a less steep Shh gradient and altered ventral neural progenitor specification.\",\n      \"method\": \"Single-cell mRNA injection of GFP-tagged Shh; morpholino knockdown; in situ hybridization for Shh protein distribution and neural progenitor markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct visualization of morphogen distribution with loss-of-function; links Sulf1 enzymatic activity to ligand gradient shaping\",\n      \"pmids\": [\"24768893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sulf1 plays an essential role in arterial specification in zebrafish by promoting VegfA165-mediated signaling; sulf1 morphants show reduced Notch and ephrinB2 expression in the dorsal aorta with increased venous marker flt4, rescued by vegfa165 mRNA co-injection.\",\n      \"method\": \"Antisense morpholino knockdown in zebrafish; vegfa165 mRNA rescue; in situ hybridization for arterial/venous markers; in vitro VEGFA-mediated signaling assays\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — morpholino knockdown with mRNA rescue and specific pathway marker analysis; in vitro confirmation\",\n      \"pmids\": [\"23959107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The HD of Sulf1 exhibits catch bond behavior with heparan sulfate; the catch bond character is attributed specifically to the 6-O-sulfation site on GAGs (slip bond only without 6-O-sulfation), characterized by two coupled slip-bond states with an energy difference of ~9 kBT.\",\n      \"method\": \"AFM-based force clamp spectroscopy; dynamic force spectroscopy; two-state two-path model analysis\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-molecule biophysics with quantitative thermodynamic characterization of binding mechanism\",\n      \"pmids\": [\"25863062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sulf1 has ligand-specific effects on Wnt signaling: it inhibits canonical Wnt8a signaling while enhancing non-canonical Wnt11b activity, and differentially affects membrane accumulation and extracellular levels of Wnt8a versus Wnt11b ligands.\",\n      \"method\": \"Wnt signaling assays in Xenopus; fluorescently tagged Wnt ligand imaging in ectodermal explants; Sulf1 overexpression\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct visualization of ligand distribution with functional signaling readouts; single lab\",\n      \"pmids\": [\"25681501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sulf1 deficiency in cerebellar granule cells results in reduced neurite length, reduced cell survival, and reduced migration capacity, correlated with Sulf-specific interference with FGF2, GDNF, and NGF signaling pathways; Sulf2 deficiency alters a specific HS epitope on cerebellar neuron surfaces.\",\n      \"method\": \"Primary cerebellar granule cells from Sulf1/Sulf2 knockout mice; neurite length measurement; survival assays; migration assays; biochemical HS analysis; HS epitope detection\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — primary cell KO with multiple orthogonal functional readouts and biochemical HS characterization\",\n      \"pmids\": [\"26448642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HSulf-1 loss promotes aerobic glycolysis (Warburg effect) in ovarian cancer by upregulating glycolytic genes (Glut1, HKII, LDHA) and blocking glucose entry into the TCA cycle via increased inhibitory phosphorylation of pyruvate dehydrogenase; mechanistically, HSulf-1 loss promotes c-Myc induction through HB-EGF-mediated p-ERK activation.\",\n      \"method\": \"shRNA silencing; HSulf-1 overexpression; metabolomic profiling; isotope tracer analysis; oxygen consumption rate measurement; pharmacological c-Myc inhibition; PG545 treatment\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — isotope tracer metabolomics plus pharmacological epistasis; multiple orthogonal methods identifying HB-EGF/ERK/c-Myc as the mechanism\",\n      \"pmids\": [\"26378042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Desulfation of heparan sulfate by Sulf1 and Sulf2 is required for corticospinal tract axon guidance; in Sulf1/2 double KO mice, increased 6-O-sulfated HS causes abnormal accumulation of Slit2 protein on brain surfaces, leading to dorsal repulsion of CST axons; in utero electroporation of Sulf1/2 into radial glial cells rescues the CST defects.\",\n      \"method\": \"Sulf1/2 double KO mice; in utero electroporation rescue; proteomic analysis; Slit2 protein localization by immunostaining; HS sulfation analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo rescue with proteomic identification of molecular substrate (Slit2); mechanistically links HS desulfation to axon guidance molecule presentation\",\n      \"pmids\": [\"29062064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRISPR/Cas9 genome-scale knockout screening confirmed SULF1 loss as contributing to cisplatin resistance in ovarian cancer cell lines, validated by CCK-8 and RT-PCR analysis.\",\n      \"method\": \"Genome-scale CRISPR/Cas9 knockout (GeCKO) screening; CCK-8 viability assay; RT-PCR\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — unbiased genome-wide screen with validation; single lab\",\n      \"pmids\": [\"31218106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SULF1, produced primarily by bone marrow fibroblasts, suppresses Wnt3A-driven growth of prostate cancer cells in a 3D perlecan-modified triculture model; M2-like macrophages increase SULF1 and HSPG2 levels in fibroblasts, and SULF1 knockout fibroblasts fail to suppress Wnt3A-mediated PCa tumoroid growth.\",\n      \"method\": \"SULF1 knockout fibroblasts; 3D bone marrow biomimetic hydrogel triculture model; co-culture with macrophages; Wnt3A treatment; tumoroid growth measurement\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO in 3D model with defined molecular readout; single lab\",\n      \"pmids\": [\"32413029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cancer-associated fibroblast-secreted SULF1 binds to TGFBR3 on gastric cancer cell membranes, interferes with the TGF-β1/TGFBR3 interaction, and subsequently activates TGF-β signaling to promote cancer cell metastasis and cisplatin resistance.\",\n      \"method\": \"Co-immunoprecipitation; CAF-derived conditioned medium experiments; SULF1 overexpression/knockdown; Western blot for TGF-β pathway components; in vivo xenograft\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP identifying TGFBR3 as binding partner; functional consequences demonstrated; single lab\",\n      \"pmids\": [\"38438372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SULF1 promotes pulmonary fibrosis by catalyzing the release of TGF-β1 bound to TGFβRIII (TGFBR3), thereby activating the TGF-β1/SMAD pathway; TGF-β1 in turn induces SULF1 expression through the TGF-β1/SMAD pathway, creating a positive feedback loop.\",\n      \"method\": \"Co-immunoprecipitation; SULF1 shRNA knockdown in HFL1 fibroblasts; Western blot for SMAD pathway; TGF-β1 ELISA; fibroblast functional assays (proliferation, migration, invasion)\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus functional assays in relevant cell type; positive feedback loop defined; single lab\",\n      \"pmids\": [\"39354547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Active human SULF1 requires co-expression of sulfatase-modifying factor 1 (SUMF1) for full enzymatic activity, which depends on conversion of the active site cysteine to Cα-formylglycine and the presence of a Ca2+ ion; marine fucosylated chondroitin sulfate inhibits SULF1 with IC50 ~0.05 μg/mL in mixed-mode inhibition.\",\n      \"method\": \"Recombinant protein expression in HEK293 cells; co-expression with SUMF1; enzymatic activity assays; kinetic analysis; inhibitor characterization\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted enzymatic activity with defined active site chemistry and quantitative inhibition kinetics\",\n      \"pmids\": [\"41025518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SULF1 interacts with thrombospondin-2 (THBS2) to regulate the TGF-β1/SMAD2/3 pathway in colon cancer; MARCHF1 ubiquitin ligase accelerates SULF1 protein degradation, thereby suppressing SULF1-driven tumor progression and 5-FU resistance.\",\n      \"method\": \"Co-immunoprecipitation of SULF1 with THBS2; MARCHF1 overexpression/knockdown; Western blot for SMAD2/3; proliferation, migration, and invasion assays; 5-FU sensitivity assay\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP identifying THBS2; MARCHF1 as a degradation mechanism; functional assays; single lab\",\n      \"pmids\": [\"41550717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Sulf1 disruption in D2-MSNs of the nucleus accumbens shell alters neural firing (smaller rheobase but blunted response to larger current), and in D1-MSNs leads to more depolarized resting membrane potentials and increased AMPA/NMDA ratio, demonstrating that Sulf1 is required for regulation of neuronal excitability and glutamatergic transmission in the adult brain.\",\n      \"method\": \"Sulf1 knockout mice; whole-cell patch-clamp recording in D1-MSNs and D2-MSNs labeled with Cre-dependent AAV-mCherry\",\n      \"journal\": \"eNeuro\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology in genetically defined cell types in KO mice; direct cellular mechanism identified\",\n      \"pmids\": [\"41381361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Sulf1 conditional knockout in D1 receptor-expressing cells impairs cocaine-induced conditioned place preference (reward learning), while Sulf1 conditional knockout in D2 receptor-expressing cells impairs inhibitory avoidance (aversion learning), demonstrating pathway-specific roles of Sulf1 in reward and aversion circuits.\",\n      \"method\": \"Sulf1 floxed mice generated by CRISPR-Cas9; Cre-mediated conditional KO in D1-Cre and D2-Cre mice; conditioned place preference and inhibitory avoidance behavioral tests\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional KO with double dissociation of behavioral phenotypes; defines pathway specificity\",\n      \"pmids\": [\"41486756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"SULF1 derived from cancer-associated fibroblasts promotes invasion of head and neck squamous cell carcinoma cells; CRISPR/Cas9-mediated SULF1 knockout in primary HNSCC CAFs reduces fibroblast proliferation and markedly impairs cancer cell migration and invasion in 2D and 3D spheroid coculture models; SULF2 expressed in tumor cells does not compensate for SULF1 loss.\",\n      \"method\": \"CRISPR/Cas9 SULF1 knockout in primary CAFs; 2D migration/invasion assays; 3D spheroid coculture with two-photon microscopy; proteomic analysis\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO in primary cells with 3D functional model; single lab\",\n      \"pmids\": [\"41549062\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SULF1 is a cell surface-associated and secreted heparan sulfate 6-O-endosulfatase that selectively removes 6-O-sulfate groups from trisulfated (N,6-O,2-O) disaccharides in heparan sulfate proteoglycan chains; this desulfation activity—which depends on an active-site Cα-formylglycine (generated by SUMF1), Ca2+, and a unique positively charged hydrophilic domain that binds HS through catch-bond mechanics—reduces the co-receptor function of HSPGs for multiple heparin-binding growth factors (FGF-2, HGF, VEGF165, HB-EGF, GDNF, Wnt ligands, Slit2) by lowering their binding affinity, thereby attenuating downstream RTK, ERK, AKT, Wnt/β-catenin, and SMAD signaling cascades; context-dependently, SULF1 can enhance or suppress specific ligand-receptor interactions (e.g., promoting GDNF signaling by releasing it from HS-sequestration, or restricting Shh gradient diffusion), and in the adult brain it regulates glutamatergic transmission and dopamine-pathway-specific reward/aversion behaviors, while its epigenetic silencing or CAF-specific expression is exploited in cancer to modulate tumor growth, angiogenesis, and drug resistance.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SULF1 is a cell-surface and secreted heparan sulfate 6-O-endosulfatase that selectively removes 6-O-sulfate groups from trisulfated disaccharide units within heparan sulfate proteoglycan (HSPG) chains, thereby remodeling the sulfation code that governs growth factor–HSPG co-receptor interactions and downstream signaling. Its catalytic activity requires SUMF1-mediated conversion of the active-site cysteine to Cα-formylglycine, Ca²⁺, and N-linked glycosylation, while a unique positively charged hydrophilic domain mediates high-affinity, catch-bond-dependent engagement with HS substrate [PMID:41025518, PMID:25863062, PMID:17855356, PMID:19666466]. By desulfating HSPGs, SULF1 diminishes HS-dependent co-receptor function for FGF-2, HGF, HB-EGF, VEGF165, and Wnt ligands, attenuating RTK, ERK, AKT, and Wnt/β-catenin signaling cascades; conversely, it can enhance GDNF signaling by releasing HS-sequestered ligand and restricts Shh morphogen gradient diffusion [PMID:12686563, PMID:14973553, PMID:16778174, PMID:17720696, PMID:24768893, PMID:21722266]. Beyond development—where Sulf1/Sulf2 double knockouts exhibit neonatal lethality with skeletal and renal defects—SULF1 regulates glutamatergic transmission and dopamine-pathway-specific reward and aversion behaviors in the adult brain, and its epigenetic silencing or cancer-associated fibroblast-restricted expression modulates tumor growth, angiogenesis, metabolic reprogramming, and chemoresistance [PMID:17593974, PMID:41381361, PMID:41486756, PMID:17310998, PMID:26378042, PMID:41549062].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"The key question of how HSPG sulfation is enzymatically regulated at the cell surface was answered by identifying HSulf-1 as a 6-O-endosulfatase that desulfates HSPGs and thereby attenuates RTK/ERK signaling downstream of FGF-2 and HB-EGF.\",\n      \"evidence\": \"Re-expression in ovarian cancer cells with measurement of HSPG sulfation, RTK phosphorylation, and ERK activation\",\n      \"pmids\": [\"12686563\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic specificity for particular HS disaccharide motifs not yet defined\", \"In vivo relevance not established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The generality of HSulf-1's signaling suppression was extended beyond FGF/EGFR to HGF/c-Met, establishing that HSPG desulfation broadly dampens HS-dependent growth factor axes including AKT signaling and cell invasion.\",\n      \"evidence\": \"Stable HSulf-1 transfection in SCCHN cells; Western blot for phospho-c-Met, phospho-ERK, phospho-AKT; transwell invasion\",\n      \"pmids\": [\"14973553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct evidence for HSPG structural changes mediating c-Met attenuation not shown\", \"Endogenous regulation of SULF1 expression unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"In vivo tumor growth suppression by SULF1/SULF2 was demonstrated, establishing their functional equivalence and anti-tumorigenic role through cell-surface sulfatase activity.\",\n      \"evidence\": \"Stable transfection in myeloma cells; SCID mouse xenograft\",\n      \"pmids\": [\"16192265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of each sulfatase individually in vivo not resolved\", \"Mechanism of ECM deposition promotion unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"HSulf-1 was shown to regulate angiogenesis by disrupting the ternary FGF-2/FGFR1c/HS complex on endothelial cells, extending its function to the tumor microvasculature and HS-dependent growth factors VEGF165 and HGF.\",\n      \"evidence\": \"shRNA knockdown in HUVECs; co-IP of FGF-2/FGFR1c/HS; Matrigel plug and xenograft assays\",\n      \"pmids\": [\"16778174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether anti-angiogenic activity operates through endothelial-autonomous or paracrine mechanisms in vivo not fully distinguished\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Several foundational questions were resolved simultaneously: Sulf1/Sulf2 double-knockout mice revealed neonatal lethality proving developmental essentiality and functional redundancy; Sulf1 was shown to enhance rather than inhibit GDNF signaling by releasing HS-sequestered ligand; N-glycosylation was identified as essential for enzymatic activity and membrane targeting; SULF1 silencing was attributed to promoter DNA methylation and histone methylation; and HSulf-1 loss was linked to autocrine EGFR-ERK activation via amphiregulin/HB-EGF.\",\n      \"evidence\": \"Double KO mice with phenotyping; GDNF binding and neurite sprouting in KO tissues; glycosylation mutants and heparin-binding assays; bisulfite sequencing and ChIP; shRNA with neutralizing antibodies in breast cancer cells\",\n      \"pmids\": [\"17593974\", \"17720696\", \"17855356\", \"17310998\", \"17363371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether single Sulf1 KO has subtle phenotypes masked by Sulf2 compensation remains unclear\", \"Structural basis of N-glycosylation requirement not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The hydrophilic domain (HD) was established as the HS-binding module with nanomolar affinity essential for enzymatic function; substrate specificity was defined as selective for trisulfated UA2S-GlcNS6S disaccharides; and transcriptional regulation by HNF1β was identified.\",\n      \"evidence\": \"SPR with HD constructs; disaccharide HPLC analysis; PI-88 inhibitor studies; ChIP and reporter assays for HNF1β binding to SULF1 promoter\",\n      \"pmids\": [\"19666466\", \"19822709\", \"19487294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model of HD–HS interaction lacking\", \"Whether PI-88 inhibition is therapeutically relevant in vivo unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"HIF-1α/HIF-2α were identified as direct transcriptional repressors of SULF1 under hypoxia, linking tumor microenvironment oxygen tension to HSPG sulfation state, and SULF1 was shown to inhibit Wnt/β-catenin signaling at the HSPG level upstream of intracellular pathway components.\",\n      \"evidence\": \"ChIP for HIF binding to SULF1 promoter HREs; Wnt reporter epistasis with Wnt3a rescue and β-catenin knockdown in gastric cancer cells\",\n      \"pmids\": [\"21266348\", \"21722266\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether hypoxic silencing of SULF1 is reversible upon reoxygenation not tested\", \"Wnt ligand specificity of SULF1 inhibition not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Organ-specific HS sulfation patterns were shown to be generated by differential Sulf1/Sulf2 activity in vivo, with Sulf1 mRNA levels correlating with tissue-specific HS desulfation.\",\n      \"evidence\": \"HPLC disaccharide analysis across organs from Sulf1 and Sulf2 KO mice\",\n      \"pmids\": [\"22298771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether organ-specific sulfation differences translate to differential growth factor responsiveness not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Sulf1's action on Wnt ligands was shown to be context-dependent: it facilitates Wingless/Wnt degradation by reducing HS binding in Drosophila, and the HD was found to use multiple cooperative HS-binding sites for processive chain editing.\",\n      \"evidence\": \"Drosophila wing disc Wg stability assays; AFM single-molecule force spectroscopy of HD subdomains\",\n      \"pmids\": [\"23300081\", \"23891937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether processivity is required in vivo not demonstrated\", \"Crystal structure of HD still unavailable\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Sulf1 was placed in developmental morphogen gradient control (restricting Shh diffusion in neural tube) and vascular specification (promoting VEGFA165/Notch signaling in arterial fate), while in cancer its loss was shown to suppress Bim expression specifically through ERK pathway activation.\",\n      \"evidence\": \"Shh gradient imaging in Xenopus morphants; zebrafish morpholino with vegfa165 rescue; ERK/PI3K inhibitor epistasis in ovarian cancer cells\",\n      \"pmids\": [\"24768893\", \"23959107\", \"24596063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Sulf1 acts on Shh directly or indirectly through HS-bound intermediates not resolved\", \"In vivo relevance of Bim regulation not confirmed in patient samples\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The biophysical mechanism of HD–HS interaction was defined as a catch bond dependent on 6-O-sulfation, providing a molecular explanation for how Sulf1 maintains productive engagement with its substrate; Sulf1 was also shown to have ligand-specific effects on Wnt signaling (inhibiting Wnt8a, enhancing Wnt11b) and to regulate cerebellar neuron survival and migration.\",\n      \"evidence\": \"AFM force-clamp spectroscopy; Wnt8a/Wnt11b signaling and imaging in Xenopus; primary cerebellar granule cells from Sulf1 KO mice\",\n      \"pmids\": [\"25863062\", \"25681501\", \"26448642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether catch bond mechanism applies to full-length enzyme on cell surfaces not confirmed\", \"Wnt ligand selectivity mechanism not structurally explained\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"SULF1 loss was linked to metabolic reprogramming (Warburg effect) in ovarian cancer through HB-EGF/ERK/c-Myc–driven upregulation of glycolytic enzymes and inhibition of pyruvate dehydrogenase.\",\n      \"evidence\": \"Isotope tracer metabolomics; oxygen consumption; c-Myc inhibitor epistasis; PG545 treatment\",\n      \"pmids\": [\"26378042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether metabolic phenotype is reversible upon SULF1 restoration in vivo not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Sulf1/2-mediated HS desulfation was shown to be required for corticospinal tract axon guidance by controlling Slit2 protein distribution on brain surfaces, with rescue by in utero electroporation.\",\n      \"evidence\": \"Sulf1/2 double KO mice; Slit2 immunostaining; in utero electroporation rescue\",\n      \"pmids\": [\"29062064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contribution of Sulf1 versus Sulf2 to CST guidance not separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Unbiased genome-scale CRISPR screening independently confirmed SULF1 loss as a contributor to cisplatin resistance in ovarian cancer.\",\n      \"evidence\": \"GeCKO library screen with CCK-8 validation\",\n      \"pmids\": [\"31218106\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of resistance beyond prior ERK/Bim findings not defined\", \"Single cell line used\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"SULF1 produced by bone marrow fibroblasts was shown to suppress Wnt3A-driven prostate cancer growth in a 3D biomimetic microenvironment, establishing its paracrine tumor-suppressive function in the stromal compartment.\",\n      \"evidence\": \"SULF1 KO fibroblasts in 3D perlecan-modified hydrogel triculture; Wnt3A stimulation\",\n      \"pmids\": [\"32413029\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo validation of fibroblast-derived SULF1 tumor suppression lacking\", \"Whether SULF1 acts on perlecan HS specifically not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A new non-enzymatic function was proposed: CAF-secreted SULF1 physically binds TGFBR3 on cancer cells, interfering with TGF-β1/TGFBR3 interaction and activating TGF-β/SMAD signaling to promote metastasis, with a positive feedback loop identified in pulmonary fibrosis.\",\n      \"evidence\": \"Co-IP of SULF1–TGFBR3; CAF conditioned medium; SMAD pathway Western blots; in vivo xenograft; fibroblast functional assays\",\n      \"pmids\": [\"38438372\", \"39354547\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the TGFBR3 interaction requires SULF1 enzymatic activity or is independent not tested\", \"Reciprocal IP validation lacking for TGFBR3 interaction\", \"Positive feedback loop not validated in vivo\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Recombinant human SULF1 was fully reconstituted, confirming SUMF1-dependent Cα-formylglycine formation and Ca²⁺ as catalytic requirements, and a potent marine fucosylated chondroitin sulfate inhibitor was characterized; separately, SULF1–THBS2 interaction was linked to TGF-β1/SMAD2/3 signaling in colon cancer, with MARCHF1 identified as an E3 ligase targeting SULF1 for degradation.\",\n      \"evidence\": \"Recombinant expression in HEK293 with SUMF1 co-expression; kinetic analysis; Co-IP of SULF1–THBS2; MARCHF1 overexpression/knockdown\",\n      \"pmids\": [\"41025518\", \"41550717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of SULF1 available\", \"MARCHF1-mediated degradation not validated in vivo\", \"Whether fCS inhibitor has therapeutic utility untested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Cell-type-specific roles of Sulf1 in the adult brain were established: Sulf1 regulates neuronal excitability and AMPA/NMDA ratios in striatal MSNs, and conditional deletion in D1- versus D2-MSNs produces a double dissociation of reward versus aversion learning; CAF-derived SULF1 was also shown to non-redundantly promote HNSCC invasion.\",\n      \"evidence\": \"Whole-cell patch clamp in D1/D2-MSNs of Sulf1 KO mice; conditional KO with behavioral testing; CRISPR KO in primary CAFs with 3D spheroid coculture\",\n      \"pmids\": [\"41381361\", \"41486756\", \"41549062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Sulf1 acts on synaptic HS to regulate glutamate receptor clustering or on growth factor signaling in neurons not distinguished\", \"Molecular targets of Sulf1 in striatal circuits unidentified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Despite extensive functional characterization, no atomic-resolution structure of SULF1 exists, the precise mechanism by which HD-mediated catch-bond processivity operates on native cell-surface HS remains unresolved, and whether the newly described protein–protein interactions (TGFBR3, THBS2) are enzymatic-activity-dependent or represent independent binding functions is unknown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure\", \"Catch-bond processivity not demonstrated on native cell surfaces\", \"Enzymatic versus non-enzymatic contributions to TGFBR3/THBS2 interactions unresolved\", \"Neuronal substrates and HS-binding partners in brain circuits unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 10, 17, 34]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 10, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 6, 9]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [2, 32, 38]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [2, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 7, 14, 16, 21, 28]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 5, 22, 23, 24]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [29, 36, 37]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [10, 17, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TGFBR3\",\n      \"THBS2\",\n      \"SUMF1\",\n      \"MARCHF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}